Development and testing of dual tasks for gait evaluation in diabetes mellitus
Not Applicable
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2023/03/050172
- Lead Sponsor
- Ashok&Rita Patel Institute of physiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Duration of diabetes more than 5 years
MoCA score less than 26
Ability to walk independently without support
HbA1C more than 7.5 percent
Exclusion Criteria
Any neurological or orthopedic conditions which cause difficulty in walking
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phase 1- Montreal cognitive assessment scale <br/ ><br>Interview guide <br/ ><br>Phase 2 - Taxonomy of tasks prepared from phase 1Timepoint: 1 year 6 months
- Secondary Outcome Measures
Name Time Method Six minutes walk test <br/ ><br>BMITimepoint: 1 year 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does type 2 diabetes mellitus with complications (E116) impact neural pathways involved in cognitive-motor integration during gait?
What is the comparative effectiveness of CTRI/2023/03/050172's dual-task gait taxonomy versus standard clinical assessments in elderly T2DM patients?
Which biomarkers correlate with gait instability in community-dwelling elderly individuals with E116 type 2 diabetes mellitus?
What adverse events are associated with gait disturbances in T2DM patients and how are they managed in observational studies?
Are there existing non-pharmacological interventions or competitor approaches for cognitive-motor gait evaluation in T2DM populations?